A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on hormone treatments for menopause, arguing that the strong warning has likely discouraged countless women from using a treatment that may provide benefit.

( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the warnings printed on hormone replacement therapy products for menopausal women because the caution labels overstate the health risks.

“Now, by expanding the palette of available colors derived from natural sources, food manufacturers have a variety of options available that will make it easier to end their use of petroleum-based dyes,” FDA Commissioner Marty Makary’s statement reads on the official website.

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for menopause that critics say have discouraged women for decades from using the pills and creams.

The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The Hill.

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.

During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's guidelines for saturated fats.

The FDA is repealing outdated food regulations, impacting items like canned fruits and dairy. Learn what’s changing and how it could affect your grocery shopping.